TCRyption
New York
About TCRyption
TCRyption is a preclinical company focused on the development of novel approaches to TCR based cellular therapy for cancer and other indications. TCRyption seeks to develop a pipeline of product candidates that can treat cancer type and patient populations that are underserved by current approaches.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $10.0M
- Funding stage: M&A
- Last round: Seed (Oct 2020)
Industries & Categories
Biotechnology, Health Care
Canonical: https://fsome.com/organization/tcryption-101420 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.